Passage from India: an outbreak of hepatitis B linked to a patient who acquired infection from health care overseas

Public Health

Volumn 121, Issue 10, 2007, Pages 734-741

  Harling, Richard ^a   Turbitt, Deborah ^b   Millar, Michael ^c   Ushiro Lumb, Ines ^c   Lacey, Sandra ^d   Xavier, Gladys ^b   Pope, Joanne ^c   Ijaz, Samreen ^b   Teo, Chong Gee ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

Communicable disease control; Hepatitis B; Hospital infection control; Outbreak

Indexed keywords

VIRUS DNA;

DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TRANSMISSION; HEPATITIS; RISK FACTOR;

AGED; ARTICLE; AWARENESS; CASE REPORT; COMMUNITY; CONTACT EXAMINATION; DATA EXTRACTION; DNA SEQUENCE; EPIDEMIC; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH PRACTITIONER; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; IMMUNE DEFICIENCY; INCUBATION TIME; INDIA; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; PATIENT ATTITUDE; PATIENT CARE; PATIENT IDENTIFICATION; RISK FACTOR; TRAVEL; VACCINATION; VIRUS GENE; VIRUS LOAD; VIRUS TRANSMISSION;

CROSS INFECTION; DISEASE OUTBREAKS; EPIDEMIOLOGIC STUDIES; GREAT BRITAIN; HEPATITIS B; HUMANS; INDIA; INFECTION CONTROL; MEDICAL AUDIT; TRAVEL;

ASIA; EURASIA; INDIA; SOUTH ASIA;

EID: 34548137712     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2007.03.010     Document Type: Article

References (39)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11 (2004) 97-107
2. NHS Executive. Health Service Guidelines HSG 93(40): protecting health care workers and patients from hepatitis B. NHS Executive, 18 August 1993.
3. NHS Executive. Health Service Circular 2000/020: Hepatitis B infected Health Care Workers.
4. Rosenheim. Hepatitis and the treatment of chronic renal failure. Report of the advisory group, 1970-1972, Department of Health and Social Security, Scottish Home and Health Department, Welsh Office.
5. Good practice guidelines for renal dialysis/transplantation units. Prevention of blood borne virus infections. Department of Health 2002.
6. Zuckerman M. Surveillance and control of blood-borne viral infections in haemodialysis units. J Hosp Infect 50 (2002) 1-5
7. De Castro L., Araujo N.M., Sabino R.R., Alvarenga F., Yoshida C.F., and Gomes S.A. Nosocomial spread of hepatitis B virus in two haemodialysis units, investigated by restriction length polymorphism analysis. Eur J Clin Microbiol Infect Dis 19 (2000) 531-537
8. Roll M., Norder H., Magnius L.O., Grillner L., and Lindgren V. Nosocomial spread of hepatitis B virus in a haemodialysis unit confirmed by HBV DNA sequencing. J Hosp Infect 30 (1995) 57-63
9. Danzig L.E., Sartor C., Selulster L., McNeely W., Cousins Jdes Vignes-Kendrick M., et al. Outbreak of HBV infection in a haemodialysis unit. Infect Control Hosp Epidemiol 16 (1995) 4-20
10. Niu M.T., Penbethy L.T., Alter M.J., Armstrong C.W., Miller G.B., and Hadley S.C. Haemodialysis associated hepatitis B: report of an outbreak. Nephrol Dial Transplant 18 (1989) 542-555
11. Carl M., Francis D.P., and Maynard J.E. A common source outbreak of hepatitis B in a haemodialysis unit. Nephrol Dial Transplant 12 (1983) 222-229
12. Anonymous. Nosocomial hepatitis B infection associated with reuseable fingerstick blood sampling devices-Ohio and New York 1996. J Am Med Assoc 277 (1997) 1106-1107
13. Polish L.B., Shapiro C.N., Bauer F., Klotz P., Ginier P., Roberto R.R., et al. Nosocomial transmission of hepatitis B virus associated with use of a spring loaded finger stick device. N Engl J Med 326 (1992) 721-725
14. Anonymous. Nosocomial transmission of hepatitis B virus associated with a spring loaded finger stick device-California. Mob Mortal Wkly Rep 39 (1990) 610-613
15. Anonymous. Nosocomial transmission of hepatitis B virus associated with a spring loaded finger stick device-United States. Can Dis Week Rep 16 (1990) 205-207
16. Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B and C viruses in outpatient settings-New York, Oklahoma, and Nebraska, 2000-2002. Mob Mortal Wkly Rep 52 (2003) 901-906
17. Kidd-Ljunggren K., Broman E., Ekvall H., and Gustavsson O. Nosocomial transmission of hepatitis B infection through multiple dose vials. J Hosp Infect 43 (1999) 57-62
18. Khan A.J., Cotter S.M., Schulz B., Hu X., Rosenberg J., Robertson B.H., et al. Nosocomial transmission of hepatitis B virus infection among residents with diabetes in a skilled nursing facility. Infect Control Hosp Epidemiol 23 (2002) 313-318
19. Dumpis U., Kovalova Z., Jansons J., Cupane L., Sominskaya I., Michail M., et al. An outbreak of HBV and HCV in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol 69 (2003) 331-338
20. Petrosillo N., Ippolito G., Solforosi L., Varaldo P.E., Clementi M., and Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol 38 (2000) 2975-2981
21. Raleigh V.S. Diabetes and hypertension in Britain's ethnic minorities: implications for the future of renal services. Br Med J 314 (1997) 209
22. Randhawa G. The impending kidney transplant crisis for the Asian population in the UK. Public Health 112 (1998) 265-268
23. World Health Organisation. Global prevalence of hepatitis A, B, and C. Wkly Epidemiol Rec 77 (2002) 6
24. Mudur G. Kidney trade arrest exposes loopholes in India's transplant laws. Br Med J 328 (2004) 246
25. Kumar S. Police uncover large scale organ trafficking in Punjab. Br Med J 326 (2003) 180
26. Ahmed M. Surgery in South Asia. Br Med J 328 (2004) 782
27. Simonsen L., Kane A., Lloyd J., Zaffran M., and Kane M. Unsafe injections in the developing world and transmission of blood borne viral infections. Bull World Health Org 77 (1999) 789-800
28. World Health Organisation. Expanded Programme on Immunization global advisory group. Wkly Epidemiol Rec 3 (1992) 11-16
29. In: Salisbury D.M., and Begg N.T. (Eds). Immunisation against infectious disease (1996), HMSO, London
30. Department of Health. Controls Assurance Standards 2003/04.
31. Saloojee H., and Steenhoff A. The health professional's role in preventing nosocomial infections. Postgrad Med J 77 (2001) 16-19
32. Zhevachevsky N.G., Nomokonova N.Y., Beklemishev A.B., and Belov G.F. Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance. J Med Virol 61 (2000) 433-438
33. Reiss-Levy E.A., Wilson C.M., Hedges M.J., and McCaughan G. Acute fulminant hepatitis B following a spit in the eye by a hepatitis B e antigen negative carrier. Med J Australia 160 (1994) 524-525
34. Kalcioglu M.T., Durmaz R., Ozturan O., Bayindir Y., and Direkel S. Does cerumen have a risk of transmission of hepatitis B. Laryngoscope 114 (2004) 577-580
35. Hayziyannis S.J., Papetheodoridis G.V., Dimou E., et al. Efficacy of long-term lanivudine monotherapy in patients with hepatitis B e antigen negative chronic hepatitis B. Hepatology 32 (2000) 847-851
36. Hayziyannis S.J., Tassopoulos N.C., Heathcote E.J., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen negative chronic hepatitis B. N Engl J Med 348 (2003) 800-807
37. Department of Health. Hepatitis B infected healthcare workers and oral antiviral therapy. July 2004.
38. Gilson R.J., Chopra K.B., Newell A.M., Murray-Lyon I.M., Nelson M.R., Rice S.J., et al. A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection. J Viral Hepatitis 6 (1999) 387-395
39. Papatheodoridos G.V., Dimou E., Laras A., et al. Course of virological breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. Hepatology 36 (2002) 219-226